Cargando…

Understanding NK cell biology for harnessing NK cell therapies: targeting cancer and beyond

Gene-engineered immune cell therapies have partially transformed cancer treatment, as exemplified by the use of chimeric antigen receptor (CAR)-T cells in certain hematologic malignancies. However, there are several limitations that need to be addressed to target more cancer types. Natural killer (N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shin, Eunju, Bak, Seong Ho, Park, Taeho, Kim, Jin Woo, Yoon, Suk-Ran, Jung, Haiyoung, Noh, Ji-Yoon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395517/ https://www.ncbi.nlm.nih.gov/pubmed/37539051 http://dx.doi.org/10.3389/fimmu.2023.1192907

Ejemplares similares

Harnessing NK Cells for Cancer Treatment
por: Minetto, Paola, et al.
Publicado: (2019)

Prostaglandin E2 Secreted by Thyroid Cancer Cells Contributes to Immune Escape Through the Suppression of Natural Killer (NK) Cell Cytotoxicity and NK Cell Differentiation
por: Park, Arum, et al.
Publicado: (2018)

Beyond NK Cells: The Expanding Universe of Innate Lymphoid Cells
por: Cella, Marina, et al.
Publicado: (2014)

Harnessing NK Cells to Control Metastasis
por: Deng, Xuewen, et al.
Publicado: (2022)

Engineered NK Cells Against Cancer and Their Potential Applications Beyond
por: Karvouni, Maria, et al.
Publicado: (2022)

SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity
por: Kim, Hanna, et al.
Publicado: (2022)

Editorial: Women in NK and innate lymphoid cell biology
por: Zingoni, Alessandra, et al.
Publicado: (2023)

NK Cell Exhaustion
por: Bi, Jiacheng, et al.
Publicado: (2017)

Harnessing NK Cell Checkpoint-Modulating Immunotherapies
por: Chauhan, Sachin Kumar Singh, et al.
Publicado: (2020)

Genetic Causes of Human NK Cell Deficiency and Their Effect on NK Cell Subsets
por: Mace, Emily M., et al.
Publicado: (2016)

Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer
por: Bödder, Johanna, et al.
Publicado: (2021)

Biological role of NK cells and immunotherapeutic approaches in breast cancer
por: Roberti, María P., et al.
Publicado: (2012)

Biology and Clinical Relevance of HCMV-Associated Adaptive NK Cells
por: Gao, Fei, et al.
Publicado: (2022)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
por: Heipertz, Erica L., et al.
Publicado: (2021)

NK cells and poxvirus infection
por: Burshtyn, Deborah N.
Publicado: (2013)

NK Cells in the Human Lungs
por: Hervier, Baptiste, et al.
Publicado: (2019)

Dazed and Confused: NK Cells
por: O'Sullivan, Timothy E.
Publicado: (2019)

Plasticity of NK cells in Cancer
por: Corvino, Dillon, et al.
Publicado: (2022)

Memory-Like NK Cells: Remembering a Previous Activation by Cytokines and NK Cell Receptors
por: Pahl, Jens H. W., et al.
Publicado: (2018)

Underlying mechanisms of evasion from NK cells as rationale for improvement of NK cell-based immunotherapies
por: Seliger, Barbara, et al.
Publicado: (2022)

Natural Killer Cells for Immunotherapy – Advantages of the NK-92 Cell Line over Blood NK Cells
por: Klingemann, Hans, et al.
Publicado: (2016)

Recognition and Regulation of T Cells by NK Cells
por: Pallmer, Katharina, et al.
Publicado: (2016)

A modifiable universal cotinine-chimeric antigen system of NK cells with multiple targets
por: Kang, Hee Young, et al.
Publicado: (2023)

Donor selection for adoptive immunotherapy with NK cells in AML patients: Comparison between analysis of lytic NK cell clones and phenotypical identification of alloreactive NK cell repertoire
por: Meazza, Raffaella, et al.
Publicado: (2023)

Endometrial Tumor Microenvironment Alters Human NK Cell Recruitment, and Resident NK Cell Phenotype and Function
por: Degos, Clara, et al.
Publicado: (2019)

Severe COVID-19 patients display hyper-activated NK cells and NK cell-platelet aggregates
por: Malengier-Devlies, Bert, et al.
Publicado: (2022)

Beyond αβ T cells: NK, iNKT, and γδT cell biology in leukemic patients and potential for off-the-shelf adoptive cell therapies for AML
por: Kent, Andrew, et al.
Publicado: (2023)

Genetic dissection of NK cell responses
por: Moussa, Peter, et al.
Publicado: (2013)

NK Cell Autoreactivity and Autoimmune Diseases
por: Poggi, Alessandro, et al.
Publicado: (2014)

Molecular Regulation of NK Cell Maturation
por: Bi, Jiacheng, et al.
Publicado: (2020)

NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019)

NK Cell Metabolism and Tumor Microenvironment
por: Terrén, Iñigo, et al.
Publicado: (2019)

NK cell exhaustion in the tumor microenvironment
por: Jia, Hao, et al.
Publicado: (2023)

Hypoxia Modifies the Transcriptome of Human NK Cells, Modulates Their Immunoregulatory Profile, and Influences NK Cell Subset Migration
por: Parodi, Monica, et al.
Publicado: (2018)

Characterization of Surface Receptor Expression and Cytotoxicity of Human NK Cells and NK Cell Subsets in Overweight and Obese Humans
por: Naujoks, Wiebke, et al.
Publicado: (2020)

Tissue-resident natural killer (NK) cells are cell lineages distinct from thymic and conventional splenic NK cells
por: Sojka, Dorothy K, et al.
Publicado: (2014)

iPSCs in NK Cell Manufacturing and NKEV Development
por: Boyd-Gibbins, Nicholas, et al.
Publicado: (2022)

Harnessing Memory NK Cell to Protect Against COVID-19
por: Soleimanian, Saeede, et al.
Publicado: (2020)

NK cells in asthma exacerbation
por: Lunding, Lars, et al.
Publicado: (2015)

Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells
por: Carlsten, Mattias, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_itlrd2go7depk2mn855k5kukge